Human RalBP1-associated Eps domain-containing protein 1 42-50, AQLANDVVL
Description
About Human RalBP1-associated Eps domain-containing protein 1 42-50, AQLANDVVL
The Human RalBP1-associated Eps domain-containing protein 1 (mutated sequence of AQLPNDVVL) Peptide (IEDB: 1090269) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The RalBP1-associated Eps domain-containing protein 1 Peptide, H-AQLANDVVL-OH (Uniprot: Q96D71 aa: 42-50) from JPT is produced under strict quality control and quality management.
Human RalBP1-associated Eps domain-containing protein 1 42-50, AQLANDVVL - Specifications
- Peptide sequence: H-AQLANDVVL-OH
- Amount: 1 mg
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Cancer
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human RalBP1-associated Eps domain-containing protein 1 42-50, AQLANDVVL
References:
Read References with JPT’s Antigen Peptides
Human RalBP1-associated Eps domain-containing protein 1 42-50, AQLANDVVL has been described in:
Co-delivery of Peptide Neoantigens and Stimulator of Interferon Genes Agonists Enhances Response to Cancer Vaccines., ACS Nano, 2020 (PMID: 32701257)
Identification of a neo-epitope dominating endogenous CD8 T cell responses to MC-38 colorectal cancer., Oncoimmunology, 2019 (PMID: 32923109)
Documentation
Documentation for Human RalBP1-associated Eps domain-containing protein 1 42-50, AQLANDVVL
Properties
Properties of Human RalBP1-associated Eps domain-containing protein 1 42-50, AQLANDVVL
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Cancer |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Protein Name: | RalBP1-associated Eps domain-containing protein 1 |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human RalBP1-associated Eps domain-containing protein 1 42-50, AQLANDVVL
Information | Values |
---|---|
Sequence: | H-AQLANDVVL-OH |
WT Sequence: | AQLPNDVVL |
Specifications: | 9mer peptide as TFA salt |